Tag: Covid‐19

SMS Pharmaceuticals gets license to Pfizer Covid‐19 drug nirmatrelvir

pallavi123- March 17, 2022

SMS Pharmaceuticals has secured a non‐exclusive license via the Medicines Patent Pool (MPP) for manufacturing nirmatrelvir, an oral antiviral Covid‐19 drug developed by Pfizer, to ... Read More